text
stringlengths
0
83
with O O O O
no O O O O
anemia O O O B-finding
and O O O O
the O O O O
platelet O O O B-finding
count O O O I-finding
was O O O O
215,000 O O O B-modifier
per O O O I-modifier
cubic O O O I-modifier
millimeter O O O I-modifier
. O O O O
Liver O O O B-finding
and O O O O
renal O O O B-finding
function O O O I-finding
tests O O O I-finding
, O O O O
blood O O O B-finding
coagulation O O O I-finding
studies O O O I-finding
and O O O O
electrolytes O O O B-finding
were O O O O
within O O O O
normal O O O B-modifier
limits O O O O
. O O O O
Our O O O O
patient O O O O
's O O O O
erythrocyte O O O B-finding
sedimentation O O O I-finding
rate O O O I-finding
( O O O O
ESR O O O B-finding
) O O O O
was O O O O
3mm/h O O O B-modifier
15 O O O O
days O O O O
prior O O O O
to O O O O
admission O O O O
and O O O O
14mm/h O O O B-modifier
at O O O O
the O O O O
hospital O O O O
. O O O O
Blood O O O B-finding
cultures O O O I-finding
were O O O B-modifier
negative O O O I-modifier
one O O O O
week O O O O
after O O O O
admission O O O O
. O O O O
Urinalysis O O O B-finding
was O O O O
normal O O O B-modifier
. O O O O
Tests O O O O
for O O O O
rheumatoid O O O B-finding
factor O O O I-finding
( O O O O
RF O O O B-finding
) O O O I-finding
, O O O O
anti O O O B-finding
nuclear O O O I-finding
antibodies O O O I-finding
( O O O O
ANA O O O B-finding
) O O O O
, O O O O
circulating O O O B-finding
anti O O O I-finding
neutrophil O O O I-finding
cytoplasmic O O O I-finding
antibody O O O I-finding
( O O O B-finding
cANCA O O O I-finding
) O O O O
, O O O O
perinuclear O O O B-finding
anti O O O I-finding
neutrophil O O O I-finding
cytoplasmic O O O I-finding
antibody O O O I-finding
( O O O B-finding
pANCA O O O I-finding